Rasio cepet: Orthofix Medical Inc. (OFIX)

Orthofix Medical Inc. (OFIX) procures raw metals and polymers from third-party partners while retaining high-precision finishing in-house. The business model relies on the express delivery of sterile kits aligned with surgical schedules, with the separate_ratio_quick coefficient standing at 1.60. This price chart illustrating cost trends clearly complements the data. Operational stability is guaranteed by the absence of trade restrictions on life-critical implants and the resilience of global supply chains.

This indicator assesses the ability of Orthofix Medical Inc. (OFIX) to settle short-term obligations using its most liquid assets, completely excluding hard-to-realize inventories from the calculation. By analyzing the acid-test ratio dynamics, an investor can see how effectively the synergy with SeaSpine and implant sales generate "liquid" funds to ensure solvency without accounting for inventory buildup, which is critical for minimizing default risks during fluctuations in operating revenue.